Acute Myeloid Leukemia Response Measures Other Than Complete Remission.
US Food and Drug Administration, Silver Spring, MD donna.przepiorka@fda.hhs.gov.
Donna
D
Przepiorka
US Food and Drug Administration, Silver Spring, MD.
Albert
A
Deisseroth
US Food and Drug Administration, Silver Spring, MD.
Ann T
AT
Farrell
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001792:Blood Platelets; D005260:Female; D006801:Humans; D060828:Induction Chemotherapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male